Short Description
Study of pharmacological protocols for the treatment of non-genetic neurodegenerative diseases using computational biomarkers. The aim is to identify the most effective therapies and evaluate how computational biomarkers can be used to monitor disease progression, predict treatment outcomes, and assess patient response


